SkinnyRx vs Medvi: Cheapest GLP-1 Access or More Coaching in 2026?

Short answer: SkinnyRx is the better fit if you want simple, lower-friction access to compounded semaglutide or tirzepatide without a coaching-heavy program. Medvi is the better fit if you are new to GLP-1s, want provider check-ins, value dietitian-style support, and are willing to pay more after the first month.

If you are ready to buy, start with the question that actually matters: do you want medication access, or do you want a more guided weight-loss program built around medication?

• Check SkinnyRx pricing
• Take the Medvi quiz
• Compare all GLP-1 providers

For a self-directed buyer who already understands GLP-1 treatment, SkinnyRx is the cleaner first stop. For a first-time buyer who wants help with nutrition, dose adjustments, side effects, and accountability, Medvi is easier to justify.

SkinnyRx vs Medvi at a glance

Who should choose SkinnyRx?

Choose SkinnyRx if you mostly want medication access and do not need a full coaching program.

PeptidePub’s SkinnyRx review describes SkinnyRx as a legitimate no-frills telehealth program for compounded GLP-1 medication delivery. It lists separate plans for compounded semaglutide and compounded tirzepatide, with consultation, shipping, monthly delivery, provider access for dose adjustments, basic messaging support, and injection supplies included.

That setup fits buyers who already know the basics:

• You understand the difference between semaglutide and tirzepatide.
• You want to choose the medication path up front.
• You are comfortable with messaging-based support.
• You do not need lifestyle coaching bundled into the price.
• You want month-to-month flexibility instead of a high-touch program.

The biggest reason to pick SkinnyRx is simplicity. You are not paying extra for a broader behavior-change program. That can be exactly right if you already have a nutrition plan, know how to ask dosing questions, and mainly need a legitimate prescription pathway.

The tradeoff is support depth. SkinnyRx is not positioned as the best option for people who want frequent video visits, intensive nutrition guidance, or proactive coaching. If you are nervous about side effects or injection instructions, the cheaper option may not feel cheaper once you need more help.

Who should choose Medvi?

Choose Medvi if you want support around the medication, not just the medication.

PeptidePub’s Medvi review positions Medvi as a more hands-on telehealth weight-loss platform. Medvi combines GLP-1 medication access with provider check-ins, nutrition guidance, meal-planning support, dose optimization, side-effect management, coaching access, and free shipping.

Medvi’s current public GLP-1 site also emphasizes 24/7 support, doctor-led plans, coaching, free dietitian visits, HSA/FSA approval, and no hidden fees. It says OpenLoop Health clinicians review eligibility and retain prescribing discretion. It also discloses that compounded GLP-1 medications are not FDA-approved or evaluated for safety, efficacy, or quality.

That matters. A provider that sells compounded GLP-1s should be clear that compounded medication is not the same regulatory product as Wegovy or Zepbound.

Medvi makes the most sense if:

• This is your first GLP-1 program.
• You want help with side effects and dose changes.
• You need accountability around food, protein, and adherence.
• You are willing to pay more for coaching and support.
• You want more than a prescription and a box in the mail.

The tradeoff is cost. Medvi’s first-month price can look close to SkinnyRx, but ongoing pricing often moves higher. If you do not use the support, you may be paying for services you do not need.

Pricing comparison: lowest friction vs higher support

Pricing changes often, so confirm directly before enrolling. Still, the current PeptidePub and public-site signals are enough to compare the shape of each program.

PeptidePub lists SkinnyRx at about $179 per month for compounded semaglutide and $249 per month for compounded tirzepatide. Search snippets and third-party coverage have also shown SkinnyRx public pricing signals around $199 per month for some semaglutide formats and higher pricing for tirzepatide. Treat those as snapshots, not guarantees.

PeptidePub lists Medvi at about $179 for the first month, then commonly $249 to $349 per month depending on medication and plan details. External pricing snippets show similar Medvi ranges, with compounded semaglutide often cheaper than tirzepatide and tablet options sometimes priced differently.

Before you enter a card, ask both providers:

1. What is the exact monthly price after month one?
2. Does the price change at higher doses?
3. Are consultation, medication, supplies, shipping, follow-up, and dose changes included?
4. Is this compounded semaglutide, compounded tirzepatide, Wegovy, Zepbound, Ozempic, or Mounjaro?
5. Which pharmacy dispenses the medication?
6. What support do I get if side effects happen?
7. What is the cancellation deadline before the next shipment?

If you mostly care about lowest possible semaglutide cost, also compare PeptidePub’s cheapest semaglutide online guide. If you are comparing multiple programs, use the provider comparison table.

Medication options and expected results

Both SkinnyRx and Medvi are access points. Your result depends on the medication, dose, adherence, side effects, medical eligibility, lifestyle support, and whether the product is compounded or FDA-approved.

Clinical trials are still useful for context.

In STEP 1, once-weekly semaglutide 2.4 mg produced 14.9% average weight loss at 68 weeks, compared with 2.4% with placebo. In SURMOUNT-1, tirzepatide produced up to 20.9% average weight loss at 72 weeks at the 15 mg dose, compared with 3.1% with placebo. In SURMOUNT-5, a head-to-head trial in adults with obesity but without diabetes, tirzepatide produced 20.2% average weight loss at 72 weeks compared with 13.7% for semaglutide.

That does not mean every SkinnyRx or Medvi patient will lose those amounts. Trial results come from controlled protocols. Compounded products, different doses, interruptions, side effects, adherence, and follow-up quality can change real-world outcomes.

The buying takeaway is practical:

• If you want lower-cost access and already know what you are doing, SkinnyRx fits.
• If you want a team helping you use the medication correctly, Medvi fits.
• If tirzepatide is affordable for you, it may offer higher average weight loss than semaglutide, but it often costs more.

For more background, read PeptidePub’s semaglutide guide, tirzepatide guide, and tirzepatide vs semaglutide comparison.

Safety checks before choosing either provider

The biggest mistake is treating every online GLP-1 program as interchangeable.

FDA warns that unapproved GLP-1 products do not go through FDA review for safety, effectiveness, and quality before marketing. FDA has raised concerns about compounded semaglutide and tirzepatide, including improper cold storage during shipping, fraudulent compounded products, dosing errors, use beyond approved-label dose schedules, and salt-form semaglutide products.

FDA also says patients should obtain a prescription from a doctor and fill it at a state-licensed pharmacy. That is the baseline.

Before choosing SkinnyRx or Medvi, verify:

• A licensed clinician reviews your medical history before prescribing.
• You know the exact medication name and whether it is compounded or brand-name.
• The dispensing pharmacy is state-licensed.
• The label is clear about concentration, dose, and injection volume.
• Refrigerated medication arrives cold when required.
• There is a support path for side effects, missed doses, and dose changes.
• The provider does not sell research vials or no-prescription GLP-1s.

Read PeptidePub’s compounded vs brand GLP-1 guide before choosing a compounded pathway.

Recommendation: SkinnyRx for access, Medvi for guidance

If I were choosing strictly for simple cash-pay access, I would start with SkinnyRx. It is cleaner for self-directed buyers who want compounded semaglutide or tirzepatide without paying for a more structured program.

If I were choosing for a first-time GLP-1 user who wants reassurance, I would start with Medvi. The extra support may be worth it if you are worried about nausea, constipation, dose changes, food choices, or staying consistent.

The best decision framework:

• Pick SkinnyRx if you want medication access first and support second.
• Pick Medvi if you want support first and medication access inside a broader program.
• Compare both against Eden Health, Direct Meds, and the full PeptidePub provider table before buying.
• If your final compounded price approaches brand-name Wegovy or Zepbound direct-pay pricing, compare the brand-name route too.

FAQ

Is SkinnyRx cheaper than Medvi?

Usually, SkinnyRx is cheaper for ongoing no-frills access based on current PeptidePub price signals. Medvi can have a similar first-month price, but ongoing costs are commonly higher because coaching and support are part of the program.

Is Medvi better than SkinnyRx?

Medvi is better if you want more help. That includes coaching, provider check-ins, nutrition support, side-effect guidance, and a more guided experience. SkinnyRx is better if you mainly want straightforward medication access.

Do SkinnyRx and Medvi sell FDA-approved GLP-1 drugs?

PeptidePub’s reviews describe both as primarily offering compounded semaglutide and compounded tirzepatide. Medvi’s current public site also references brand-name Wegovy and Zepbound pathways with membership plus medication cost. Confirm the exact medication before paying because compounded and FDA-approved products are not the same regulatory category.

Which is better for tirzepatide?

SkinnyRx is the better first check if you want a simpler tirzepatide access path at a lower listed price signal. Medvi is the better first check if you want more guidance while using tirzepatide and are comfortable paying more for support.

Should I choose the cheapest GLP-1 provider?

Not automatically. Price matters, but the cheapest program is not always the best fit. Verify pharmacy credentials, clinical oversight, support access, shipping practices, dose clarity, cancellation terms, and whether the medication is compounded or brand-name.

Related posts

• Best Online Weight Loss Programs
• Cheapest Semaglutide Online
• GLP-1 Without Insurance

Sources

• PeptidePub SkinnyRx review, checked May 25, 2026.
• PeptidePub Medvi review, checked May 25, 2026.
• PeptidePub provider comparison, checked May 25, 2026.
• SkinnyRx public site and search snippets, checked May 25, 2026.
• Medvi public GLP-1 site, checked May 25, 2026.
• FDA. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.
• Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
• Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
• American College of Cardiology summary of SURMOUNT-5 head-to-head tirzepatide vs semaglutide results, 2025.